TVCMALL brings one-stop wholesale solution to MWC 2023
10.3.2023 15:57:00 EET | Business Wire | Press release
Recently, the 2023 Mobile World Congress (MWC) held in Barcelona turned out to be a big success. More than 88,000 attendees and 2400+ exhibitors participated in this event, including many cell phone accessories suppliers & wholesalers. As Europe's leading one-stop shop for mobile accessories and wholesale/integrated supply chain service platform, TVCMALL participated in this digital/mobile feast. TVCMALL, based in Shenzhen China, the world's electronic center, provides the esteemed customer B2B solution on mobile accessories for wholesale, sourcing, and customization. Various classic mobile cases with leather finishing, chargers with multifunctions, and Amorus portable Karaoke speaker brought by TVCMALL were highly praised by our attendees.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230307005650/en/
TVCMALL brings one-stop wholesale solution to MWC 2023 (Photo: Business Wire)
MWC is one of the world's most important telecommunications & technology shows. During the past 4 days, the aspects such as the latest trend in mobile technologies, including Intelligent equipment, 5G network, AI, and digitalization, have been introduced and shared with the world.
During the show, TVCMALL met a lot of old customers and new friends. Many of them are as follows:
- Top online mobile phone accessories retailers & distributors
- B2C platform sellers, Dropshippers
- Offline chain stores, Supermarket sellers, Telecom companies
- Gift-Customize customers (especially for government, corporate & schools and other agents)
- OEM & ODM & OBM customers
- Retail shops & Mobile phone repair shops
Many customers have cooperated with TVCMALL for over ten years since its establishment in 2008, and they have grown and developed rapidly with TVCMALL. They expressed their high recognition and gratitude to TVCMALL for providing one-stop wholesale, sourcing, customized services, and other supply chain services.
Why they choose TVCMALL as an indispensable and important long-term partner? Because TVCMALL provides complete product catalog, with more than 600,000 SKU online, and every week 6,000 new products updated. Its wholesale process, marketing support, and customer service are efficient. TVCMALL has good intention of growing together with their customers.
TVCMALL's comprehensive procurement cost is relatively low, the service consistency and stability are very strong. That’s why many customers prefer one-stop service providers like TVCMALL.
During the MWC, TVCMALL has established a bridge of contact with some excellent product suppliers and e-commerce service providers (of mobile, 3C electronic devices and accessories).
In the foreseeable future, with continuously TVCMALL brand and platform upgrading, TVCMALL will strengthen its mission, "To help entrepreneurs actualize their dreams of launching and sustaining a successful retail business", and will stick to its business operation philosophy "Together we thrive". In terms of specific strategies, TVCMALL will adhere to the following 4 directions:
- Platform Branding — Operate the TVCMALL platform as a future century-old brand
- Productization of the services — all the services of TVCMALL with the idea of Productization.
- Product Deep ploughing — Thrive to be the best.
- Localization of TVCMALL service — Go global and localization: Initiate local marketing and service team, in-depth understanding & efficient service.
TVCMALL will see you again in Barcelona 2024!
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230307005650/en/
Contact information
Shenzhen Zhenzhi Technology Co.,Ltd.
Yelly Huang
global@tvcmall.com
https://www.tvcmall.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
U.S. FDA Grants Priority Review to BeOne Medicines’ TEVIMBRA in First-Line HER2+ GEA29.4.2026 13:00:00 EEST | Press release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the U.S. Food and Drug Administration (FDA) has granted Priority Review to a supplemental Biologics License Application (sBLA) for TEVIMBRA® (tislelizumab) in combination with ZIIHERA® (zanidatamab) and chemotherapy for the first-line treatment of unresectable locally advanced/metastatic HER2-positive (HER2) gastric, gastroesophageal junction, or esophageal adenocarcinoma. The FDA has also granted Breakthrough Therapy Designation to the regimen of ZIIHERA in combination with fluoropyrimidine- and platinum-containing chemotherapy, with and without TEVIMBRA, in this indication. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors, BeOne Medicines, said: “HERIZON‑GEA‑01 has the potential to shift the treatment paradigm in this historically difficult-to-treat disease, with the TEVIMBRA-containing arm demonstrating an unprecedented 26-month survival benefit. The FDA’s Prior
European Commission (EC) Approves Henlius and Organon’s POHERDY ® (pertuzumab), the First Approved Biosimilar to PERJETA (pertuzumab) in Europe29.4.2026 12:30:00 EEST | Press release
Shanghai Henlius Biotech, Inc. (2696.HK), and Organon (NYSE: OGN) today announced the European Commission (EC) has granted marketing authorization for POHERDY® (pertuzumab) 420 mg/14 mL injection for intravenous use, the first and only approved biosimilar to PERJETA (pertuzumab) in Europe, for all indications of the reference product.1 This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260429686426/en/ “As the first, and currently the only, pertuzumab biosimilar in Europe, the EC’s approval of POHERDY marks an important milestone in expanding access to treatments for patients with certain HER2-positive breast cancers, particularly as breast cancer is the most commonly diagnosed cancer among women in the European Union,” said Joe Azzinaro, Vice President, Global Commercial Lead Biosimilars, at Organon.2,3 “Organon’s growing global portfolio of biosimilars reinforces our ongoing commitment to supporting the sustainability of healt
CORRECTING and REPLACING Yoshihiro Shimamura, a Leading Investor in Japan’s Entertainment Industry, to Host Workshop at the 2026 Cannes Film Festival29.4.2026 11:49:00 EEST | Press release
Headline of release dated April 27, 2026 should read: Yoshihiro Shimamura, a Leading Investor in Japan’s Entertainment Industry, to Host Workshop at the 2026 Cannes Film Festival The updated release reads: YOSHIHIRO SHIMAMURA, A LEADING INVESTOR IN JAPAN’S ENTERTAINMENT INDUSTRY, TO HOST WORKSHOP AT THE 2026 CANNES FILM FESTIVAL Shimamura Yoshihiro Film Planning Inc. (Head Office: Osaka, Japan; CEO: Yoshihiro Shimamura), a company engaged in film production and investment, will host a workshop in France during this year’s Cannes Film Festival, as part of its commitment to further advancing the entertainment industry. The company invests in leading entertainment-related businesses in Japan and places strong emphasis on long-term value creation. It identifies the cultural and entertainment sectors as high-growth areas and is actively involved in international co-productions as a core part of its film production activities. As a recent investment, the company acquired 2,000,000 shares of
Andreas Goppelt Appointed Managing Director of OrphaCare29.4.2026 11:27:00 EEST | Press release
OrphaCare, a global specialist for the development and marketing of medical devices for drug delivery and part of the AOP Health Group, has appointed Andreas Goppelt as its new Managing Director, succeeding Georg Fischer. In this role, the seasoned medical device expert will focus on broadening the company’s strategic scope and driving its next phase of growth. OrphaCare plays a key role in supporting AOP Health’s integrated therapies approach, and the Group’s long-term expansion. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260429303533/en/ Portrait Andreas Goppelt, Managing Director OrphaCare (copyright: AOP Health/Studio Koekart) Andreas Goppelt brings more than 25 years of leadership experience across MedTech, biotechnology and the pharmaceutical industry. He has a proven track record of driving innovation, scaling global organizations, and delivering growth in highly regulated healthcare environments. In his new role,
The Jury Has Been Announced for the Third Edition of the Reply AI Film Festival, Dedicated to the Best Short Films Generated With Artificial Intelligence29.4.2026 11:00:00 EEST | Press release
Reply [EXM, STAR: REY], an international group specialized in creating new business models enabled by AI and long committed to guiding younger generations in exploring emerging technologies, presents the jury of the third edition of the Reply AI Film Festival, the international competition aimed at creatives, directors, and filmmakers who want to challenge themselves in producing short films created using Artificial Intelligence tools. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260429288361/en/ “Imaginatio Nova” is the theme of the 2026 edition, an invitation to explore a new phase of imagination, where human creativity is renewed through technology. Leading the jury will be Gabriele Salvatores, Italian director and screenwriter known for films such as Nirvana, Siberian Education, and Napoli - New York, and Academy Award® winner for Best Foreign Language Film with Mediterraneo. Joining him on the panel for the third edit
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom